Literature DB >> 2575622

Is pregnancy the best treatment for hyperprolactinaemia?

P G Crosignani1, A M Mattei, C Scarduelli, V Cavioni, P Boracchi.   

Abstract

This paper reports the changes in prolactin levels after 12 spontaneous and 52 induced pregnancies in 54 women with unambiguous hyperprolactinaemia (median plasma prolactin levels 67.5 ng/ml, range 40-400). Twenty-three of the patients showed radiological evidence of prolactinoma. The pregnancies were induced in 37 patients by bromocriptine, in nine by metergoline, in two by lisuride and in four by other treatments. Of the 64 pregnancies, 16 ended in spontaneous abortion, while 48 went to term. Follow-up was continued for at least 6 months after delivery or until the end of lactation. In a control group of 32 hyperprolactinaemic women (median prolactin 70 ng/ml, range 40-400) not wishing to become pregnant, prolactin changes were similarly registered over a mean period of 15 months without any treatment (range 6-38 months). After pregnancy, a significant downward trend of plasma prolactin was observed in the puerperal women with a 'normalization' rate of 17%. No changes were observed in the 32 controls who did not become pregnant.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2575622     DOI: 10.1093/oxfordjournals.humrep.a137010

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  7 in total

1.  A Brazilian multicentre study evaluating pregnancies induced by cabergoline in patients harboring prolactinomas.

Authors:  B G Sant' Anna; N R C Musolino; M R Gadelha; C Marques; M Castro; P C L Elias; L Vilar; R Lyra; M R A Martins; A R P Quidute; J Abucham; D Nazato; H M Garmes; M L C Fontana; C L Boguszewski; C B Bueno; M A Czepielewski; E S Portes; V S Nunes-Nogueira; A Ribeiro-Oliveira; R P V Francisco; M D Bronstein; A Glezer
Journal:  Pituitary       Date:  2020-04       Impact factor: 4.107

Review 2.  Pituitary tumors and pregnancy: the interplay between a pathologic condition and a physiologic status.

Authors:  Rosario Pivonello; Maria Cristina De Martino; Renata S Auriemma; Carlo Alviggi; Ludovica F S Grasso; Alessia Cozzolino; Monica De Leo; Giuseppe De Placido; Annamaria Colao; Gaetano Lombardi
Journal:  J Endocrinol Invest       Date:  2014-01-16       Impact factor: 4.256

Review 3.  Treatment of hyperprolactinemia: a systematic review and meta-analysis.

Authors:  Amy T Wang; Rebecca J Mullan; Melanie A Lane; Ahmad Hazem; Chaithra Prasad; Nicola W Gathaiya; M Mercè Fernández-Balsells; Amy Bagatto; Fernando Coto-Yglesias; Jantey Carey; Tarig A Elraiyah; Patricia J Erwin; Gunjan Y Gandhi; Victor M Montori; Mohammad Hassan Murad
Journal:  Syst Rev       Date:  2012-07-24

4.  Management of prolactinoma with cabergoline treatment in a pregnant woman during her entire pregnancy.

Authors:  Sukhwinder Kaur Bajwa; Sukhminder Jit Singh Bajwa; Praveen Mohan; Anita Singh
Journal:  Indian J Endocrinol Metab       Date:  2011-09

5.  Second Attempt of Cabergoline Withdrawal in Patients with Prolactinomas after a Failed First Attempt: Is it Worthwhile?

Authors:  Lucio Vilar; José Luciano Albuquerque; Patrícia Sampaio Gadelha; Frederico Rangel Filho; Aline Maria C Siqueira; Maíra Melo da Fonseca; Karoline Frazão Viana; Barbara Sales Gomes; Ruy Lyra
Journal:  Front Endocrinol (Lausanne)       Date:  2015-02-04       Impact factor: 5.555

Review 6.  Management of Endocrinopathies in Pregnancy: A Review of Current Evidence.

Authors:  Daniela Calina; Anca Oana Docea; Kirill Sergeyevich Golokhvast; Stavros Sifakis; Aristides Tsatsakis; Antonis Makrigiannakis
Journal:  Int J Environ Res Public Health       Date:  2019-03-04       Impact factor: 3.390

7.  Prolactinoma Outcome After Pregnancy and Lactation: A Cohort Study.

Authors:  Bashir A Laway; Mohammad S Baba; Sailesh K Bansiwal; Naseer A Choh
Journal:  Indian J Endocrinol Metab       Date:  2022-02-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.